PATENT CLAIM ANALYSIS

Application Number: 15763248
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "303000"]

Abstract:
Compounds of formula (I): wherein R 1 , R 2 , R 3 , R 4 , and R 5  are as defined in the description. Medicinal products containing the same which are useful in treating cancer, neurodegenerative disorders and metabolic disorders.

Claim (Index 45):
The compound according to  claim 34 , which is selected from the group consisting of:\n 4-[2-methyl-3-(3-phenylcyclobutyl)-3H-imidazo[4,5-b]pyridin-5-yl]pyridine-2,6-diamine, 4-[3-(3,3-difluorocyclobutyl)-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl]pyridine-2,6-diamine, 4-(3-{2-[(6-fluoropyridin-2-yl)oxy]ethyl}-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl)pyridine-2,6-diamine, 4-{3-[(1R,2R)-2-benzylcyclopropyl]-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl}pyridin-2,6-diamine, 4-[3-(3-fluorocyclobutyl)-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl]pyridine-2,6-diamine, 4-(3-hexyl-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl)pyridine-2,6-diamine, 4-(3-cyclobutyl-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl)pyridine-2,6-diamine, 4-[3-(2-{[6-(difluoromethyl)pyridin-2-yl]oxy}ethyl)-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl]pyridine-2,6-diamine, 4-[3-(5-methoxy-2,3-dihydro-1H-inden-2-yl)-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl]pyridin-2,6-diamine, 4-(3-ethyl-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl)pyridine-2,6-diamine, 4-[2-methyl-3-(2-{[6-(trifluoromethyl)pyridin-2-yl]oxy}ethyl)-3H-imidazo[4,5-b]pyridin-5-yl]pyridine-2,6-diamine, 4-{3-[2-(2-methoxycyclohexyl)ethyl]-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl}pyridine-2,6-diamine, 4-(2-methyl-3-pentyl-3H-imidazo[4,5-b]pyridin-5-yl)pyridine-2,6-diamine, 4-(3-cyclohexyl-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl)pyridine-2,6-diamine, 4-{2-methyl-3-[3-(methylsulfanyl)propyl]-3H-imidazo[4,5-b]pyridin-5-yl}pyridine-2,6-diamine, 4-{3-[(1R,2S)-2-benzylcyclopropyl]-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl}pyridine-2,6-diamine, 4-{2-methyl-3-[2-(2-methylphenyl)ethyl]-3H-imidazo[4,5-b]pyridin-5-yl}pyridine-2,6-diamine, 4-(3-{2-[(6-chloropyridin-2-yl)oxy]ethyl}-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl)pyridine-2,6-diamine, 4-(3-{(2R)-2-[(6-fluoropyridin-2-yl)oxy]propyl}-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl)pyridine-2,6-diamine, 4-[2-methyl-3-(2,2,2-trifluoroethyl)-3H-imidazo[4,5-b]pyridin-5-yl]pyridine-2,6-diamine, 3-cyclopentyl-5-(2,6-diaminopyridin-4-yl)-3H-imidazo[4,5-b]pyridine-2-carbonitrile, 4-(3-cyclopropyl-2-methyl-3H-imidazo[4,5-b]pyridin-5-yl)pyridine-2,6-diamine, and its enantiomers and diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base.

Metadata:
- Claim Count in Document: 62.0
- Percentile: 90.0
- Lexical Diversity: 1.41176
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['13266976', '14389336', '10524204', '11939735', '12089050']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8110015188644332
- 35 USC 102 Novelty (BERT): 0.5409341178142105
- Combined Prediction Score: 0.7839947787594109
- Mean Citation Score: 355.59789000000006
- Max Citation Score: 376.5085
- Similarity Product: 296.8344743255973

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test